tm logo
AM-PHARMA
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 19 Jan 2023

Last Applicant/ Owned by

NL-3521 AZ Utrecht

NL

Serial Number

79311483 filed on 28th Jan 2021

Registration Number

N/A

Correspondent Address

James C. Watson

James C. Watson

230 South 500 East, #300

Salt Lake City UT 84102

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AM-PHARMA

Scientific and technological services, as well as research and design related thereto , in the field of kidney disease and kidney dysfunction; research in the scientific, technological and industrial fields in the field of kidney disease and kidney dysfunction; industrial analysis and industrial research services in the field of kidney disease and kidney dysfunction; development of technologies, d Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Provision of short-term care medical services in intensive care units and hospitals; services of hygiene and beauty care for people; consultancy and information related to short-term care biopharmaceutical products provided in intensive care units and hospitals; short-term care pharmaceutical consultancy provided in intensive care units and hospitals; provision of news and information in the field of short-term care medicines provided in intensive care units and hospitals; medical services for diagnosis of diseases of the human body provided in intensive care units and hospitals

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, as well as research and design related thereto , in the field of kidney disease and kidney dysfunction; research in the scientific, technological and industrial fields in the field of kidney disease and kidney dysfunction; industrial analysis and industrial research services in the field of kidney disease and kidney dysfunction; development of technologies, diagnostics, drugs, personal care products, and devices for others in the field of kidney disease and kidney dysfunction; biotechnological research in the field of enzymatic synthesis; testing, authentication and quality control; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; pharmaceutical research; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical development of drugs; testing of pharmaceutical products; pharmaceutical drug development services; consulting in the field of pharmaceutical research; clinical research and research in the medical field relating to kidney disease and kidney dysfunction; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for others in the field of pharmaceutical products for the treatment of kidney disease and kidney dysfunction

Class [005]
Pharmaceutical Products


Pharmaceutical, medical and veterinary preparations for the treatment and prevention of kidney diseases and kidney dysfunction; plasters for medical purposes, adhesive bandages; disinfectants; dietary supplements for medical purposes; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of kidney disease and kidney dysfunction; pharmaceutical drugs for the treatment of kidney diseases and kidney dysfunction; pharmaceutical preparations to treat kidney diseases and kidney dysfunction

Mark Details


Serial Number

No 79311483

Mark Type

No Service Mark

Attorney Docket Number

No TM4225MMUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Feb 2024FINAL DECISION TRANSACTION PROCESSED BY IB
19th Jan 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19th Jan 2024FINAL DISPOSITION NOTICE SENT TO IB
19th Jan 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
19th Jan 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
14th Nov 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26th Oct 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26th Oct 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07th Jul 2022NON-FINAL ACTION WRITTEN
07th Jul 2022NON-FINAL ACTION E-MAILED